Trials / Recruiting
RecruitingNCT06959082
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
A Multi-center, Randomized, Open-label, Parallel-group, Phase 2 Study to Evaluate the Efficacy and Safety of VS-101 in Combination With Chemoradiotherapy (CRT) in Patients With Head and Neck Cancer
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- VSPharmTech Co.,Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VS-101 | VS-101 |
| DRUG | Cisplatin | Cisplatin |
| RADIATION | Radiation | Radiation |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2025-05-06
- Last updated
- 2026-03-11
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06959082. Inclusion in this directory is not an endorsement.